Lower intestinal endoscopy (of which the major part is colonoscopy) is an extremely common procedure in most developed countries. In Australia, about 435,000 were performed between July 2003 to June 2004 1 , most with some form of conscious sedation. At present, little is known about the risks of sedation in this group of patients. Morbidity figures have focused more on complications of the endoscopy (e.g. bowel perforation) rather than the sedation 2 . While all sedation is associated with some risk, are there particular risks in patients undergoing colonoscopy?
Colonoscopy patients differ from most other day care anaesthesia patients, because they need routine pre-operative bowel preparation. All bowel preparation regimens require exclusion of high residue foods for 48 hours and intake of clear fluids only for 24 hours before the procedure. The common preparations administered depend upon local preferences, but may include phosphate preparations (e.g. Fleet phosphor-soda mixture, CB Fleet, Braeside, Victoria), polyethylene glycol preparations (e.g. ColonLYTELY, Dendy, Brighton East, Victoria), diphenylmethanes (such as bisacodyl and sodium picosulphate), magnesium preparations (e.g. Picoprep, Pharmatel, Hornsby, N.S.W.), or a combination of the above. These products produce osmotic diarrhoea and stimulate bowel peristalsis. This results in significant fluid shifts with 1 to 4 litres fluid loss, and potential hyperphosphataemia, hypocalcaemia, and other electrolyte disturbances 3 . Some regimens require patients to drink a lot of clear fluid, which, if over-enthusiastic, could lead to hyponatraemia. Other patients may become nauseated and not tolerate oral intake. Patients will also fast for a variable interval pre-operatively. Given these conditions, many patients will have a significant fluid deficit when presenting for colonoscopy. This deficit is often overlooked.
What are the implications of a pre-existing fluid deficit when conscious sedation is planned? In this issue, Leslie and colleagues report a high incidence of hypotension in patients sedated with fentanyl and propofol for elective colonoscopy 4 . They report an incidence of hypotension, defined as a 25% or greater drop in systolic blood pressure (SBP) (compared to the pre-sedation value) of 25-45%. In most instances, the hypotension was mild (SBP <100 mmHg), but in a considerable number, moderate falls were observed (SBP <85 mmHg). In a randomized double-blind controlled trial, they evaluated the effect of administering 15 ml/kg of Hartmann's solution intravenously pre-procedure (vs 1.5 ml/kg as a control) on the incidence of hypotension. They found that this volume did not significantly reduce the incidence of hypotension. There was also no benefit in reducing postoperative thirst, nausea and vomiting, headache, drowsiness, or dizziness (although these were secondary outcome measures).
The study by Leslie and colleagues demonstrates how a well-conducted trial can provide an unambiguous answer to a specific question-in this case, that routine intravenous prophylactic infusion of 15 ml/kg of Hartmann's solution to colonoscopy patients cannot be justified. This is important information, given that routine intravenous fluid therapy is time-consuming and expensive, and is not without its own risks.
Nevertheless, there are several caveats to the study, which the authors clearly outlined. Firstly, the study did not assess the effect of larger fluid volumes, which have been used in previous studies on outpatients 5 . Secondly, the trial was not designed to, and had insufficient power to identify specific subgroups of colonoscopy patients who may benefit from prophylactic fluid loading. We know that many patients undergoing colonoscopy are elderly or have significant co-morbidities. It is possible that these patients may benefit from intravenous fluid therapy. Indeed, Leslie and colleagues found a higher incidence of hypotension in patients over 50 years of age. Unfortunately, questions about volumes required and subgroups cannot be answered until further research is performed in this area. Until then, the possibility of significant fluid deficits should not be overlooked in more high-risk colonoscopy patients, and decisions about intravenous fluid therapy should be made on a patient-by-patient basis.
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